In patients with an aggressive form of breast cancer, treatment with the antibody-drug conjugate sacituzumab govitecan plus ...

Antimicrobial resistance directly causes more than 1 million deaths every year and contributes to more than 35 million more, ...

Urinary tract infections are common and unpleasant, but a research team at Vanderbilt University has developed a ...

Asandeutertinib is a derivative of Tagrisso designed to avoid certain toxic side effects in patients with EGFR-mutated NSCLC.